Skip to main content

Edmund K Waller

NIH Rank #1783
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1882046Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$2.7M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#1,783
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Edmund K Waller. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Edmund K Waller as a PI. Multi-PI records show the full award amount for context.

  • 5R44CA285206-03R44
    Development of a Novel Immunotherapeutic for Acute Myeloid Leukemia
    $1.1M
    award amount
  • 5R01CA287866-03R01
    Leveraging CD26high Meso-CAR T cells in patients with advanced pancreatic cancer
    $638.9K
    award amount
  • 1R01CA314282-01R01
    Targeting VIP–VPAC Signaling to Reverse Immune Exclusion and Enhance Immunotherapy Response in Pancreatic Cancer
    $636.4K
    award amount
  • 1R21CA307819-01R21
    Targeting androgen-driven resistance to immune checkpoint inhibitors in pancreatic ductal adenocarcinoma
    $402.4K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Edmund K Waller as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Emory University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6102
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding
  9. 2026
    Entered Top 25% Nationally
    Ranked #1783
  10. 2026
    Entered Top 10% Nationally
    Ranked #1783